The Pharma Data
AUGUST 28, 2020
The Department of Health and Social Care (DHSC) said this could include training a wider range of existing NHS staff, as well as student doctors and nurses. UK signs deals for 90 million virus vaccine doses. It might also involve training other professionals, including dentists and vets. Media playback is unsupported on your device.
The Pharma Data
DECEMBER 30, 2020
Their experienced medical field staff of 1,500 EMTs, paramedics and licensed practical nurses work under the guidance of MD1 Medical Care PC to fill the gap between a visit to the doctor’s office and a traditional telemedicine call.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Codon
JANUARY 21, 2024
2 AP: A news story in Nature about your organization, 1Day Sooner, discussed some recent challenge trials involving the hepatitis C virus. We wouldn't do a challenge trial for Ebola, because the disease is extremely severe, and there are currently no licensed treatments or vaccines. That's not coincidental.
The Pharma Data
JANUARY 12, 2021
. “Patients in our antibody cocktail outpatient clinical trial experienced significant reductions in virus levels and required fewer medical visits for COVID-19, suggesting the therapy can help reduce the current burden on hospitals and healthcare systems,” said George D. Yancopoulos , M.D.,
The Pharma Data
NOVEMBER 5, 2020
The trial is supported by a grant to the University of Oxford from UK Research and Innovation / National Institute for Health Research (NIHR) and by core funding provided by NIHR Oxford Biomedical Research Centre , Wellcome , the Bill and Melinda Gates Foundation , the Department for International Development , Health Data Research UK , the (..)
The Pharma Data
DECEMBER 17, 2020
About casirivimab and imdevimab Casirivimab and imdevimab (formerly known as REGN-COV2 or REGEN-COV2) is a cocktail of two monoclonal antibodies (also known as REGN10933 and REGN10987, respectively) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19.
The Pharma Data
DECEMBER 29, 2020
The EUA is temporary and does not take the place of a formal biologics license application (BLA) submission review and approval process and the use of the antibody cocktail remains investigational. Food and Drug Administration (FDA) in high-risk patients who have confirmed COVID-19 but are not currently hospitalized.
Expert insights. Personalized for you.
52 
Let's personalize your content